Ganding, Tayas H.
HRN: 23 16 40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2023
FLUCONAZOLE 50MG (CAP)
06/22/2023
06/28/2023
PO
200mg
OD
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes